Riskpilot← Back to searchSign inGet full accessSTORKEREDEN ApS
APSActiveCVR 34607079Sorøvej 108Traditional, complementary and alternative medicine activities · NACE 8696Est. 20127 employeeswww.storkereden.nu
Revenue 2024
DKK 1,1M
-31% vs 2023
EBITDA margin
-5.2%
-110% vs 2023
Equity ratio
-62.4%
Financial strength
Net profit 2024
DKK -773K
-306% vs 2023
| Revenue | DKK 1,1M | -31% |
| EBITDA | DKK -60K | -110% |
| Net profit | DKK -773K | -306% |
| Total assets | DKK 914K | -2% |
| Equity | DKK -570K | -381% |
| Employees | 7 | — |
Legal name
STORKEREDEN ApS
CVR number
34607079
Legal form
Anpartsselskab
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
27. juni 2012
Share capital
DKK 120.000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er at drive fødeklinik samt anden dermed beslægtet virksomhed.
Address
Sorøvej 108
Phone
+4526840400
Email
info@storkereden.nu
Website
www.storkereden.nu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 221 | 442 | 1.084 | 1.187 | 3.616 | 5.335 | 3.708 | 2.327 | 1.547 | 693 | 926 | 1.647 | 1.142 |
| Staff expenses | -261 | -313 | -984 | -1.585 | -3.095 | -4.234 | -4.234 | -3.685 | -1.743 | -391 | -688 | -1.046 | -1.202 |
| EBITDA | -41 | 128 | 100 | -397 | 522 | 1.101 | -526 | -1.390 | -197 | 302 | 238 | 601 | -60 |
| Depreciation & amort. | -40 | -48 | -62 | -82 | -133 | -190 | -191 | -185 | -132 | -98 | -44 | -5 | -41 |
| EBIT | -81 | 81 | 38 | -480 | 389 | 911 | -717 | -1.575 | -328 | 204 | 194 | 596 | -100 |
| Net financials | -0 | -15 | -25 | -52 | -101 | -73 | 69 | -138 | -40 | -26 | -16 | -90 | -700 |
| Profit before tax | -81 | 66 | 13 | -531 | 288 | 838 | -648 | -1.713 | -368 | 178 | 178 | 506 | -800 |
| Tax | -20 | 25 | -2 | -2 | -0 | 162 | -164 | -362 | -53 | 42 | 41 | 131 | -27 |
| Net profit | -61 | 41 | 15 | -529 | 288 | 677 | -484 | -1.351 | -315 | 137 | 137 | 375 | -773 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 240 | 770 | 649 | 1.174 | 2.023 | 3.773 | 2.328 | 1.902 | 978 | 575 | 651 | 936 | 914 |
| Equity | 193 | 235 | 249 | -380 | -92 | 1.784 | 1.221 | -130 | -445 | -309 | -172 | 203 | -570 |
| Long-term debt | 0 | 0 | 0 | 0 | 237 | 884 | 499 | 1.180 | 866 | 684 | 637 | 499 | 558 |
| Short-term debt | 47 | 531 | 398 | 1.554 | 1.878 | 943 | 608 | 852 | 557 | 199 | 185 | 234 | 349 |
| Total debt | 47 | 531 | 398 | 1.554 | 2.115 | 1.827 | 1.107 | 2.032 | 1.423 | 883 | 823 | 733 | 907 |
EBITDA margin
-5.2%
This company
15.8%
Market median
-133% vs market
20122024
Equity ratio
-62.4%
This company
38.2%
Market median
-263% vs market
20122024
Return on equity
-77309300.0%
This company
18.4%
Market median
-420159339% vs market
20122024
Net profit margin
-67.7%
This company
8.1%
Market median
-936% vs market
20122024
Asset turnover
1.25×
This company
1.12×
Market median
+12% vs market
20122024
Debt / equity
2.60×
This company
0.62×
Market median
-319% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2011-12-30 – 2012-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2017 | — | — | |
| Deputy Chairman | 2017 | — | — | |
| Board of Directors | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2017 | |
C.C.HOLDING 2000 A/S | Company | 33.3% | 33.3% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
STORKEREDEN ApS 
Save Stemcell Center ApSBoard members of STORKEREDEN ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jesper Bøge | Chairman | 0 companies |
| Teddy Kær Jacobsen | Deputy Chairman | 0 companies |
| Jens Erik Zielinski | Board of Directors | 0 companies |